The immunobiological functions and therapeutic applications of interleukin-17 family in cancer

Curr Res Transl Med. 2025 Jul 2;73(4):103527. doi: 10.1016/j.retram.2025.103527. Online ahead of print.

Abstract

Interleukin-17 (IL-17) family cytokines play a pivotal role in immune responses and inflammatory processes, significantly impacting various physiological and pathological conditions. This review explores the immunobiological functions of IL-17, focusing on its diverse cellular sources, including T helper 17 (Th17) cells, γδ T cells, innate lymphoid cells (ILCs), neutrophils, and natural killer T (NKT) cells, and signaling pathways. Special attention is given to IL-17 involvement in cancer, where it exhibits both pro-tumorigenic and anti-tumorigenic effects, influencing tumor proliferation, angiogenesis, metastasis, and drug resistance through various signaling cascades such as JAK/STAT, NF-κB, and PI3K/AKT. Understanding these mechanisms highlights IL-17 as a potential therapeutic target for modulating immune responses and improving cancer treatments.

Keywords: Cancer immunotherapy; Cytokine; IL-17; Th17; Tumor; Tumor microenvironment.

Publication types

  • Review